Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Harrow Now Offering Fortisite Formulations for In-Office Use

Harrow announced the availability of Fortisite (compounded Tobramycin 1.5% + Vancomycin 5%) for in-office use from its FDA-registered and FDA-inspected ImprimisRx 503B outsourcing facility. Fortisite formulations are high-concentration, refrigeration-stable, fortified antibiotic formulations in solution that are patent-pending. According to Harrow,…

RCA Acquires Retina Group of New England

Retina Consultants of America (RCA) announced it has added Retina Group of New England (RGNE) into its network of physicians. With this expansion, RCA will enter its 30th partnership and open operations in Connecticut, expanding its presence to 20 states…

FDA Greenlights Genentech’s Vabysmo | OBN

The FDA has approved Genentech’s Vabysmo (faricimab-svoa) for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME), marking the first bispecific antibody approved for the eye. Vabysmo is also the first and only FDA-approved injectable eye…

Amgen to Buy Horizon Therapeutics

Amgen announced it is acquiring rare disease drug company Horizon Therapeutics, maker of eye disease drugs Tepezza and Uplizna, in a deal valued at $27.8 billion. The company will pay $116.50 in cash per share, a premium of 19.7% to…

Alcon’s New Eye Health Education and Training Center I OBN

Alcon has officially inaugurated the new Alcon Experience Center (AEC) in Barcelona, one of Europe’s largest eye health education and training facilities, providing eye care professionals with the chance to learn about and practice the latest advancements in ophthalmology and…

AAO Guidelines For Standardizing Images In Ophthalmology I OBN

Ophthalmic imaging device makers have been urged to standardize image formats in order to adhere to the Digital Imaging and Communications in Medicine (DICOM) standard, according to a recent report by the American Academy of Ophthalmology. By establishing a uniform…

Rayner’s RayOne EMV IOL Approved By FDA I OBN

Since producing the first IOL in the world in 1949, Rayner has led the way in innovation, focusing on giving you and your patients the best IOLs and opthalmic solutions while always being guided by research to enhance patient outcomes…

Stay informed and not overwhelmed, subscribe now!